BETA DRUGS LIMITED : AZERBAIJAN ONCOLOGY MARKET EXPANSION

• Beta Drugs received approvals for its oncology portfolio across multiple dosage forms in Azerbaijan. • The company has filed 15 oncology product dossiers for registration and expects to file 15 more within the next month. • Beta Drugs expects to be among a few oncology players in the Azerbaijan market. • The company is working towards commercialisation and securing initial oncology business from Azerbaijan in the current financial year. • This expansion is a strategic step to build its international oncology franchise.

Beta Drugs Limited

Open attachment

← Back to feed